Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast | Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration | NCT03063619 | M.D. Anderson Cancer Center | Active, not recruiting |
| Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... | Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery | NCT02598557 | National Cancer Institute (NCI) | Active, not recruiting |
| Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma | Aspirin, Laboratory Biomarker Analysis, Placebo Administration, Questionnaire Administration | NCT02965703 | National Cancer Institute (NCI) | Active, not recruiting |
| Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful... | Aspirin, Laboratory Biomarker Analysis, Placebo Administration, Questionnaire Administration | NCT02521285 | National Cancer Institute (NCI) | Active, not recruiting |
| Broccoli Sprout/Broccoli Seed Extract Supplement in Decreasing Toxicity in Heavy Smokers | Broccoli Sprout/Broccoli Seed Extract Supplement, Laboratory Biomarker Analysis, Questionnaire Administration | NCT03402230 | National Cancer Institute (NCI) | Active, not recruiting |
| Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric... | Curcumin, Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment | NCT02782949 | National Cancer Institute (NCI) | Active, not recruiting |
| Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis | Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration | NCT03278925 | National Cancer Institute (NCI) | Recruiting |
| DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection | Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid | NCT02772003 | National Cancer Institute (NCI) | Active, not recruiting |
| Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver | Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment | NCT02273362 | National Cancer Institute (NCI) | Active, not recruiting |
| Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous... | Erlotinib, Erlotinib Hydrochloride | NCT02961374 | National Cancer Institute (NCI) | Active, not recruiting |
Why I Joined a Clinical Trial
I participated in a clinical trial because I want to help pave the way in research for others to have the opportunity to live comfortably, proudly and happily. Our cancer does not define us -we CAN control our lives. This research helped me and I know that it will help many others out there gain strength and relief.